DELINA DAVIS-COOLEY: Open Payments
NPI 1508844358 · RICH SQUARE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 55 payments from 19 companies in 2025. Trend: 2023 $1,300 · 2024 $1,278 · 2025 $896
Food & beverage: $896
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $136 |
| Exact Sciences Corporation | 7 | $134 |
| GlaxoSmithKline, LLC. | 6 | $107 |
| AstraZeneca Pharmaceuticals LP | 5 | $95 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| Corcept Therapeutics | 3 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| ABBVIE INC. | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Merck Sharp & Dohme LLC | 2 | $29 |
Products named: Cologuard Collection Kit, TRELEGY ELLIPTA, REXULTI, FARXIGA, Korlym, Rybelsus, XIFAXAN, Ozempic.
Industry payments across NC — which companies pay providers there.
